Terms: = Breast cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Treatment
61 results:
1. [Identification of breast cancer subtypes based on graph convolutional network].
An Y; Liu X; Chen H; Wan G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2024 Feb; 41(1):121-128. PubMed ID: 38403612
[TBL] [Abstract] [Full Text] [Related]
2. Triple Primary cancers: An Analysis of Genetic and Environmental Factors.
Borja NA; Silva-Smith R; Calfa C; Sussman DA; Tekin M
Cancer Prev Res (Phila); 2024 May; 17(5):209-215. PubMed ID: 38361103
[TBL] [Abstract] [Full Text] [Related]
3. Ultrasound-based radiomics nomogram for predicting axillary lymph node metastasis in early-stage breast cancer.
Zhang W; Wang S; Wang Y; Sun J; Wei H; Xue W; Dong X; Wang X
Radiol Med; 2024 Feb; 129(2):211-221. PubMed ID: 38280058
[TBL] [Abstract] [Full Text] [Related]
4. Using Radiomics to Differentiate Brain Metastases From Lung cancer Versus breast cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C
J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368
[TBL] [Abstract] [Full Text] [Related]
5. [Real-world study of the consumption between 2017 and 2020 of anti-cancer medications that inhibit cyclin- dependent kinases 4 and 6].
Expert A; Robba L; de Lagasnerie G; Kujas P
Bull Cancer; 2023 Dec; 110(12):1272-1278. PubMed ID: 37802713
[TBL] [Abstract] [Full Text] [Related]
6. PR status is a more decisive factor in efficacy of adding pertuzumab into neoadjuvant therapy for HER2-positive and lymph node-positive breast cancer than ER status: a real-world retrospective study in China.
Liu X; Liu Z; Li C; Song X; Wang X; Li S; Yu Z
World J Surg Oncol; 2023 Sep; 21(1):296. PubMed ID: 37723497
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.
Seesaghur A; Egger P; Warden J; Abbasi A; Levick B; Riaz M; McMahon P; Thompson M; Cheeseman S
BMJ Open; 2023 May; 13(5):e069214. PubMed ID: 37156580
[TBL] [Abstract] [Full Text] [Related]
8. Identification of a Novel Gene Signature with DDR and EMT Difunctionalities for Predicting Prognosis, Immune Activity, and Drug Response in breast cancer.
Zhang P; Li Q; Zhang Y; Wang Q; Yan J; Shen A; Hu B
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673982
[TBL] [Abstract] [Full Text] [Related]
9. Detection and classification of breast lesions with You Only Look Once version 5.
Meng M; Zhang M; Shen D; He G; Guo Y
Future Oncol; 2022 Dec; 18(39):4361-4370. PubMed ID: 36519579
[TBL] [Abstract] [Full Text] [Related]
10. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study.
Wang DD; Zhang JF; Zhang LH; Niu M; Jiang HJ; Jia FC; Feng ST
Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):594-604. PubMed ID: 36456428
[TBL] [Abstract] [Full Text] [Related]
11. Effect of postmastectomy radiotherapy on pT1-2N1 breast cancer patients with different molecular subtypes: A real-world study based on the inverse probability of treatment weighting method.
Ye S; Hu W
Medicine (Baltimore); 2022 Sep; 101(37):e30610. PubMed ID: 36123865
[TBL] [Abstract] [Full Text] [Related]
12. Early drug development in solid tumours: analysis of National cancer Institute-sponsored phase 1 trials.
Chihara D; Lin R; Flowers CR; Finnigan SR; Cordes LM; Fukuda Y; Huang EP; Rubinstein LV; Nastoupil LJ; Ivy SP; Doroshow JH; Takebe N
Lancet; 2022 Aug; 400(10351):512-521. PubMed ID: 35964611
[TBL] [Abstract] [Full Text] [Related]
13. Prevalent versus incident breast cancers: benefits of clinical and radiological monitoring in women with pathogenic BRCA1/2 variants.
Saule C; Menu-Hespel S; Carton M; Malhaire C; Cherel P; Reyal F; Le Mentec M; Guillot E; Donnadieu A; Callet N; Frank S; Coussy F; Stoppa-Lyonnet D; Mouret-Fourme E
Eur J Hum Genet; 2022 Sep; 30(9):1060-1066. PubMed ID: 35217802
[TBL] [Abstract] [Full Text] [Related]
14. Impact of Skeletal Muscle Loss and Visceral Obesity Measured Using Serial CT on the Prognosis of Operable breast cancers in Asian Patients.
Kwon MR; Ko ES; Park MS; Jeong WK; Hwang NY; Kim JH; Lee JE; Kim SW; Yu JH; Han BK; Ko EY; Choi JS; Park KW
Korean J Radiol; 2022 Feb; 23(2):159-171. PubMed ID: 35029082
[TBL] [Abstract] [Full Text] [Related]
15. Aberrant Methylation of 21 MicroRNA Genes in breast cancer: Sets of Genes Associated with Progression and a System of Markers for Predicting Metastasis.
Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Lukina SS; Kazubskaya TP; Karpukhin AV; Khodyrev DS; Braga EA
Bull Exp Biol Med; 2021 Nov; 172(1):67-71. PubMed ID: 34792716
[TBL] [Abstract] [Full Text] [Related]
16. Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer.
Negrao MV; Skoulidis F; Montesion M; Schulze K; Bara I; Shen V; Xu H; Hu S; Sui D; Elamin YY; Le X; Goldberg ME; Murugesan K; Wu CJ; Zhang J; Barreto DS; Robichaux JP; Reuben A; Cascone T; Gay CM; Mitchell KG; Hong L; Rinsurongkawong W; Roth JA; Swisher SG; Lee J; Tsao A; Papadimitrakopoulou V; Gibbons DL; Glisson BS; Singal G; Miller VA; Alexander B; Frampton G; Albacker LA; Shames D; Zhang J; Heymach JV
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34376553
[TBL] [Abstract] [Full Text] [Related]
17. Assessment of Modifiable Factors for the Association of Marital Status With cancer-Specific Survival.
Chen ZH; Yang KB; Zhang YZ; Wu CF; Wen DW; Lv JW; Zhu GL; Du XJ; Chen L; Zhou GQ; Liu Q; Sun Y; Ma J; Xu C; Lin L
JAMA Netw Open; 2021 May; 4(5):e2111813. PubMed ID: 34047792
[TBL] [Abstract] [Full Text] [Related]
18. The flavonoid, kaempferol-3-O-apiofuranosyl-7-O-rhamnopyranosyl, as a potential therapeutic agent for breast cancer with a promoting effect on ovarian function.
Harrath AH; Jalouli M; Oueslati MH; Farah MA; Feriani A; Aldahmash W; Aldawood N; Al-Anazi K; Falodah F; Swelum A; Alwasel S
Phytother Res; 2021 Nov; 35(11):6170-6180. PubMed ID: 33908658
[TBL] [Abstract] [Full Text] [Related]
19. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Piccart M; van 't Veer LJ; Poncet C; Lopes Cardozo JMN; Delaloge S; Pierga JY; Vuylsteke P; Brain E; Vrijaldenhoven S; Neijenhuis PA; Causeret S; Smilde TJ; Viale G; Glas AM; Delorenzi M; Sotiriou C; Rubio IT; Kümmel S; Zoppoli G; Thompson AM; Matos E; Zaman K; Hilbers F; Fumagalli D; Ravdin P; Knox S; Tryfonidis K; Peric A; Meulemans B; Bogaerts J; Cardoso F; Rutgers EJT
Lancet Oncol; 2021 Apr; 22(4):476-488. PubMed ID: 33721561
[TBL] [Abstract] [Full Text] [Related]
20. LncRNA PRNCR1 Promotes breast cancer Proliferation and Inhibits Apoptosis by Modulating microRNA-377/ccnd2/MEK/MAPK Axis.
Ouyang J; Liu Z; Yuan X; Long C; Chen X; Wang Y; Liu L; Liu S; Liang H
Arch Med Res; 2021 Jul; 52(5):471-482. PubMed ID: 33608112
[TBL] [Abstract] [Full Text] [Related]
[Next]
